Grassley launches inquiry into orphan drugs after KHN investigation

Kaiser Health News

10 February 2017 - Republican Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, has opened an inquiry into potential abuses of the Orphan Drug Act that may have contributed to high prices on commonly used drugs.

In a statement, Grassley said the inquiry is “based on reporting from Kaiser Health News” and strong consumer concern about high drug prices.

“My staff is meeting with interested groups and other Senate staff to get their views on the extent of the problem and how we might fix it,” Grassley wrote on 3 February, adding that he will continue to work on bringing prices down in other ways as well.

Read Kaiser Health News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Orphan drug , Regulation , Review , Process